Patient Preference and Adherence 12:1975-198 (2018). https://doi.org/10.2147/PPA.S164819
Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany
Pharmacoepidemiology Drug Safety 27(9):953-961 (2018). https://doi.org/10.1002/pds.4584
The impact of different strategies to handle missing data on both precision and bias in a drug safety study: a multidatabase multinational population-based cohort study
Clinical Epidemiology 10:643-654. (2018). https://doi.org/10.2147/CLEP.S154914
Cohort Profile: The Epidemiology of Chronic Diseases and Multimorbidity. The EpiChron Cohort Study
International Journal of Epidemiology 47(2):382-384f (2018). https://doi.org/10.1093/ije/dyx259
Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort
PLoS One 13(2):e0193143 (2018). https://doi.org/10.1371/journal.pone.0193143
Joint Action on Chronic Diseases and Promoting Healthy Ageing Across the Life Cycle (JA-CHRODIS). Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS)
Health Policy 122(1):4-11 (2018). https://doi.org/10.1016/j.healthpol.2017.09.006
Multimorbidity and immigrant status: associations with area of origin and length of residence in host country
Family Practice 34(6):662-666 (2017). https://doi.org/10.1093/fampra/cmx048
Hypovitaminosis D: Searching for the evidence
Endocrinology, Diabetes and Nutrition 64(9):512-513 (2017). https://doi.org/10.1016/j.endinu.2017.07.005
Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization
J Gerontol A Biol Sci Med Sci 72(10):1417-1423 (2017). https://doi.org/10.1093/gerona/glw233
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA
J Nutr Health Aging 21(1):92-104 (2017). https://doi.org/10.1007/s12603-016-0803-1